No paperwork, no hassle. We keep things digital, easy and regular.
*Zero Spam Policy. You will need to confirm your email address to receive our news to your inbox.
Une Technologie d’ici Pour Mieux Diagnostiquer le Cancer du Poumon – Local Technology for Improved
Vancouver, British Columbia – (August 30th, 2023) – BioMark Diagnostics Inc. (“BioMark”) (CSE: BUX) (FSE:
Form 7 Monthly Progress Report August 2023 Name of Listed Issuer: Trading Symbol: Number of
JAPAN PATENT OFFICE (JPO) ISSUED BIOMARK PATENT WITH CLAIMS COVERING ITS LUNG CANCER URINE BASED
BioMark Issues Statement on Recent Market Activity and Provides a Brief Corporate Update Vancouver, British
1 604 370 0779
130 3851 Shell Road
Richmond BC
Canada V6X 2W2